glp 1 risks long term GLP-1 has changed the conversation around weight loss—but it's important to understand what it can and cannot do. It's not the right choice for everyone, and it's not a replacement for healthy GLP‐1 Agonists for Pediatric Psychopharmacology:

Choline bitartrate and inositol meet USP monograph standards

GLP-1-H24-4 (Phase Ib) Results GLP-1-H24-4 Trial Design GLP-1-H24-4 was conducted with 24-25 overweight, obese, pre- or type 2 diabetic patients in each of the five study arms (n=126), of which 4 arms evaluated various DehydraTECH formulations with the 5th being the Study control arm

any effects on GLP-1 pathways appear indirect and considerably less potent than prescription GLP-1 receptor agonists

L-theanine prevent quinolinic acid induced motor deficit and striatal neurotoxicity: reduction in oxido-nitrosative stress and restoration of striatal neurotransmitters level

My body was telling me, Hey, we need a little time-out, and I listened. One of the most valuable lessons she learned